Kurt Gish

Medicine · Health Sciences

14h-index6.0kcitations30works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(6), Cell Adhesion Molecules Research(6), Bacterial Genetics and Biotechnology(4), Monoclonal and Polyclonal Antibodies Research(4), Glycosylation and Glycoproteins Research(3)

Publications30 total

Supplementary Figure Legends from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Table S1 from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Table S1 from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Supplementary Figure Legends from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Supplementary Figures S1-S7 from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Data from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Data from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Supplementary Figures S1-S7 from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Abstract 953: LRRC15 is a novel antigen in sarcoma and the therapeutic target of the antibody-drug conjugate (ADC) ABBV-085
Cancer Research·2018· 4 cited
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
Cancer Research·2018· 189 cited
ABBV-085 is a novel antibody–drug conjugate (ADC) that targets LRRC15 in the tumor microenvironment
European Journal of Cancer·2016· 2 cited
Confirming human antibody responses to a therapeutic monoclonal antibody using a statistical approach
Journal of Immunological Methods·2006· 14 cited
Sa.139. Induction of CD8+ Regulatory T-Cells by Visilizumab In Vitro
Clinical Immunology·2006
Sa.3. Efficacy of an Anti-Mouse Cd3 Fc Modified Antibody On Experimental Autoimmune Encephalomyelitis(EAE)
Clinical Immunology·2006
Towards a Unified Approach to New Target Discovery in Breast Cancer: Combining the Power of Genomics, Proteomics and Immunology
2005
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer
Proceedings of the National Academy of Sciences·2005· 233 citedOpen Access
Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers
Oncogene·2004· 105 cited
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer
Oncogene·2003· 115 cited
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.
PubMed·2003· 230 cited
Detailed gene copy number and RNA expression analysis of the 17q12–23 region in primary breast cancers
Genes Chromosomes and Cancer·2003· 28 cited
page 1 of 2Next →

Frequent Co-authors

Sonia G. Tanlimco(11), Jonathan A. Hickson(11), Mien Sho(11), Diane Hollenbaugh(11), Susan E. Morgan-Lappe(11), Eric D. Hsi(11), Debra T. Chao(11), James W. Purcell(10), Melvin Fox(10), Lisa Durkin(10), Tamar Uziel(10), Rick Powers(10), Thomas McGonigal(10), Josue Samayoa(10), Subashri Kumar(9), Joann P. Palma(9), Kelly Foster(8), Sasmita Mishra(8), David H. Mack(5), Dong Zhang(5)